[go: up one dir, main page]

HN1997000088A - BIARYLACETYLENE AS INHIBITORS OF MATRIX METALOPROTEASE - Google Patents

BIARYLACETYLENE AS INHIBITORS OF MATRIX METALOPROTEASE

Info

Publication number
HN1997000088A
HN1997000088A HN1997000088A HN1997000088A HN1997000088A HN 1997000088 A HN1997000088 A HN 1997000088A HN 1997000088 A HN1997000088 A HN 1997000088A HN 1997000088 A HN1997000088 A HN 1997000088A HN 1997000088 A HN1997000088 A HN 1997000088A
Authority
HN
Honduras
Prior art keywords
biarylacetylene
inhibitors
metaloprotease
matrix
matrix metaloprotease
Prior art date
Application number
HN1997000088A
Other languages
Spanish (es)
Original Assignee
Corporation Bayer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corporation Bayer filed Critical Corporation Bayer
Publication of HN1997000088A publication Critical patent/HN1997000088A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A BIARILACETILENOS COMO INHIBIDORES DE LA METALOPROTEASA DE MATRIZTHIS INVENTION REFERS TO BIARYLACETYLENE AS INHIBITORS OF MATRIX METALOPROTEASE

HN1997000088A 1996-05-15 1997-05-12 BIARYLACETYLENE AS INHIBITORS OF MATRIX METALOPROTEASE HN1997000088A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64502896A 1996-05-15 1996-05-15

Publications (1)

Publication Number Publication Date
HN1997000088A true HN1997000088A (en) 1997-06-18

Family

ID=24587368

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1997000088A HN1997000088A (en) 1996-05-15 1997-05-12 BIARYLACETYLENE AS INHIBITORS OF MATRIX METALOPROTEASE

Country Status (18)

Country Link
EP (1) EP0912496A1 (en)
JP (1) JP3090957B2 (en)
CN (1) CN1139570C (en)
AR (1) AR007097A1 (en)
AU (1) AU710759B2 (en)
BR (1) BR9709077A (en)
CA (1) CA2253796C (en)
CO (1) CO5080759A1 (en)
HN (1) HN1997000088A (en)
HR (1) HRP970245B1 (en)
ID (1) ID16910A (en)
PA (1) PA8429301A1 (en)
SV (1) SV1997000035A (en)
TN (1) TNSN97084A1 (en)
TW (1) TW381079B (en)
WO (1) WO1997043245A1 (en)
YU (1) YU18697A (en)
ZA (1) ZA974031B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288063B1 (en) 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
AR035478A1 (en) * 1999-01-27 2004-06-02 Wyeth Corp AMIDA-HYDROXAMIC ACID, ACETYLLENE, BETA-SULPHONAMIDE AND PHOSPHINIC ACID AS INHIBITORS OF TACE, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
US6326516B1 (en) 1999-01-27 2001-12-04 American Cyanamid Company Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
EP1031349A1 (en) * 1999-02-25 2000-08-30 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
HUE030114T2 (en) * 2010-07-08 2017-04-28 Kaken Pharma Co Ltd N-hydroxyformamide derivative and pharmaceutical containing same
JP2017509665A (en) 2014-04-03 2017-04-06 バイエル ファーマ アクチエンゲゼルシャフト 2,5-Disubstituted cyclopentanecarboxylic acids for the treatment of airway diseases
US20170022171A1 (en) 2014-04-03 2017-01-26 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentanecarboxylic acids and their use
US20170119776A1 (en) 2014-04-03 2017-05-04 Bayer Pharma Aktiengesellschaft Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
DE2112716A1 (en) * 1971-03-17 1972-10-05 Thomae Gmbh Dr K Biphenylyl-butyric acid derivs. - anti phlogistics
FR2378741A1 (en) 1977-02-01 1978-08-25 Fabre Sa Pierre GARYL GOXO ISOVALERIC ACIDS WITH ANTIPHLOGISTIC AND ANTALGIC PROPERTIES
US5789434A (en) 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
ZA974033B (en) 1996-05-15 1998-02-19 Bayer Ag Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors.

Also Published As

Publication number Publication date
ID16910A (en) 1997-11-20
JP3090957B2 (en) 2000-09-25
JPH11511179A (en) 1999-09-28
ZA974031B (en) 1998-02-19
BR9709077A (en) 1999-08-03
CN1139570C (en) 2004-02-25
CO5080759A1 (en) 2001-09-25
HRP970245A2 (en) 1998-04-30
AU710759B2 (en) 1999-09-30
TNSN97084A1 (en) 2005-03-15
TW381079B (en) 2000-02-01
CA2253796A1 (en) 1997-11-20
WO1997043245A1 (en) 1997-11-20
CA2253796C (en) 2003-10-28
YU18697A (en) 1999-11-22
SV1997000035A (en) 1999-01-14
PA8429301A1 (en) 2000-05-24
CN1225623A (en) 1999-08-11
AU2938697A (en) 1997-12-05
HRP970245B1 (en) 2002-06-30
AR007097A1 (en) 1999-10-13
EP0912496A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
HN1997000166A (en) 1-PESTICIDED ARILPIRAZOLES
HN1998000139A (en) PIRIMIDIN-4-ONA AND PIRIMIDIN-4-TIONA NOVEL AS FUNGUICIDES
SV1995000074A (en) ACIDOS 4-BIARILBUTIRICO OR 5-BIARILPENTANOICO SUBSTITUTED AND ITS DERIVATIVES AS INHIBITORS OF THE METALLOPROTEASES OF THE MATRIX
HN1997000023A (en) LACTAMA DERIVATIVES
HN1997000090A (en) PIRIDILPIRROL COMPOUNDS
HN1997000146A (en) DERIVATIVES OF CONDENSED BICYCLIC PIRIMIDINE
HN1999000089A (en) ZIPRASIDONE FORMULATIONS
HN1998000159A (en) DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA
HN2002000291A (en) ALKINS AS METHOD PROTEINASA MATRIX INHIBITORS
HN1998000168A (en) DERIVATIVES OF TIENAPIRIMIDINE AND THENAPIRIDINE USEFUL AS ANTI-CANCER AGENTS.
ES2176755T3 (en) USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF AMIOTROPHIC LATERAL SCLEROSIS.
HN1997000099A (en) MATRIX METALOPROTEASE INHIBITORS BASED ON
HN1996000101A (en) COMBINED THERAPY FOR OSTEOPOROSIS
HN1999000221A (en) CCR5 MODULATORS
AR008861A1 (en) ARALQUILO AND ARALQUILEDENO LETAMIC AND IMIDA LACTAM COMPOUNDS, INTERMEDIARY COMPOUNDS FOR YOUR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
HN1998000174A (en) EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE
HN1998000030A (en) 2-AMINO-6- (4FENOXI-2-SUBSTITUTED) -PIRIDINES SUBSTITUTED
HN1997000088A (en) BIARYLACETYLENE AS INHIBITORS OF MATRIX METALOPROTEASE
HN1998000158A (en) ISOQUINOLINS
HN1998000185A (en) COMBINATIONS OF STADINE-CARBOXYALKYL ETHER
HN1998000199A (en) THERAPEUTIC AGENTS
ES2185956T3 (en) COMPOSITIONS AND PROCEDURE FOR THE MANUFACTURE OF SENSORS OF SELECTED ION ELECTRODES.
HN1998000102A (en) SOLTRILIZED COMPOSITIONS OF SERTRALINA
HN1997000071A (en) INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED FENETILE COMPOUNDS
ES2103131T3 (en) NEW CARBOCICLIC NUCLEOSIDE AGENTS USEFUL AS SELECTIVE INHIBITORS OF PRO-INFLAMMATORY CYTOKINES.